Company news
QuidelOrtho Corporation news in 2025
QuidelOrtho Corporation's news releases, calls and decks from 2025, newest first.
Innovating Diagnostics and What's Next
December 18, 2025
QuidelOrtho To Participate In Upcoming Investor Conferences
November 23, 2025
The Power of Prevention: Detecting Diabetes Before It Strikes
November 20, 2025
QuidelOrtho Reports Third Quarter 2025 Financial Results
November 4, 2025
QuidelOrtho Receives FDA 510(k) Clearance for VITROS™ Immunodiagnostic Products hs Troponin I Assay
November 2, 2025
Informatics Illuminated: Science Bytes Podcast Explores the Power Behind Smarter Diagnostics
October 23, 2025
QuidelOrtho to Report Third Quarter 2025 Financial Results
October 21, 2025
QuidelOrtho Showcases Leadership in Transfusion Medicine at AABB 2025
October 15, 2025
Through Shades of Illness: Science Bytes Podcast Discusses Why Testing Matters
September 25, 2025
QuidelOrtho Announces Availability of QUICKVUE™ Influenza + SARS Test for Professional Use
September 21, 2025
QuidelOrtho to Participate in the Baird 2025 Global Healthcare Conference
August 27, 2025
Science Bytes Podcast Explores How Diagnostics Can Help Protect Students and Communities
August 21, 2025
QuidelOrtho Completes Debt Refinancing
August 20, 2025
QuidelOrtho Welcomes Erich Wolff as Executive Vice President, Strategy & Corporate Development
August 18, 2025
QuidelOrtho Launches Certified Analyzer Program
August 12, 2025
QuidelOrtho Reports Second Quarter 2025 Financial Results
August 4, 2025
QuidelOrtho Recognized with Three Awards in 2025 IMV ServiceTrak™
July 28, 2025
Urgent Need for Early Detection in Drug Overdose Cases Highlighted in New Podcast
July 24, 2025
QuidelOrtho to Report Second Quarter 2025 Financial Results
July 21, 2025
Real Labs, Actual Decisions With Actionable Six Sigma Metrics
July 17, 2025
QuidelOrtho and BÜHLMANN laboratories ag announce availability of fecal calprotectin (fCAL®) turbo and fecal pancreatic elastase (fPELA®) turbo assays on VITROS™ systems as a microtip™ partnership assay (mpa)
July 13, 2025
QuidelOrtho Strengthens Leadership Team With Appointments of Senior Vice Presidents for Global Quality and Clinical & Regulatory Affairs
July 6, 2025
QuidelOrtho Announces Strategy to Accelerate Growth in Molecular Diagnostics
June 2, 2025
QuidelOrtho to Participate in Upcoming Investor Conferences
May 21, 2025
QuidelOrtho Reports First Quarter 2025 Financial Results
May 6, 2025
QuidelOrtho to Report First Quarter 2025 Financial Results
April 22, 2025
QuidelOrtho® Introduces Results Manager™ System
March 9, 2025
QuidelOrtho to Participate in the 46th Annual Raymond James Institutional Investor Conference
February 23, 2025
QuidelOrtho Reports Fourth Quarter and Full-Year 2024 Financial Results
February 11, 2025
QuidelOrtho Announces Preliminary Unaudited Revenue for Fourth Quarter 2024
January 12, 2025
Calls in 2025
Decks in 2025
- Q3 2025 Earnings Presentation
Earnings · 20 slides · Nov 5, 2025
- Q2 2025 Earnings Presentation
Earnings · 18 slides · Aug 5, 2025
- William Blair 45th Annual Growth Stock Conference 2025
Conference · 28 slides · Jun 4, 2025
- Merger or Acquisition (June 2025)
Merger or acquisition · 7 slides · Jun 3, 2025
- Q1 2025 Earnings Presentation
Earnings · 17 slides · May 7, 2025
- Raymond James 46th Annual Institutional Investor Conference (March 2025)
Conference · 28 slides · Mar 5, 2025
- Q4 2024 Earnings Presentation
Earnings · 18 slides · Feb 12, 2025
- J.P. Morgan 43rd Annual Healthcare Conference (January 2025)
Conference · 20 slides · Jan 13, 2025
- 43rd Annual J.P. Morgan Healthcare Conference 2025
Conference · 21 slides · Jan 13, 2025